Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Jackman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Science (London, England : 1979)|March 1, 1991
Diurnal blood pressure variation in quadriplegic chronic spinal cord injury patientsH Krum, W J Louis, D J Brown, et al.
European Journal of Pharmacology|March 17, 1999
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptorsS N Louis, T L Nero, D Iakovidis, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Role of beta-adrenergic receptor subtypes in lipolysisS N Louis, G P Jackman, T L Nero, et al.
Journal of the Autonomic Nervous System|December 16, 1998
Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brainA R Hosseini, G P Jackman, P R King, et al.
Journal of the Autonomic Nervous System|December 16, 1998
[3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidneyP R King, S Suzuki, A R Hosseini, et al.
British Journal of Clinical Pharmacology|February 1, 1995
The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesionsK Komersova, J W Rogerson, E L Conway, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Science (London, England : 1979)|March 1, 1991
Diurnal blood pressure variation in quadriplegic chronic spinal cord injury patientsH Krum, W J Louis, D J Brown, et al.
European Journal of Pharmacology|March 17, 1999
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptorsS N Louis, T L Nero, D Iakovidis, et al.
Cardiovascular Drugs and Therapy|April 13, 2001
Role of beta-adrenergic receptor subtypes in lipolysisS N Louis, G P Jackman, T L Nero, et al.
Journal of the Autonomic Nervous System|December 16, 1998
Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brainA R Hosseini, G P Jackman, P R King, et al.
Journal of the Autonomic Nervous System|December 16, 1998
[3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidneyP R King, S Suzuki, A R Hosseini, et al.
British Journal of Clinical Pharmacology|February 1, 1995
The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesionsK Komersova, J W Rogerson, E L Conway, et al.
Pageof 2